Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lymphatic vessel contractility refers to the intrinsic ability of collecting lymphatic vessels to generate rhythmic, coordinated contractions that propel lymph fluid through the lymphatic system. This process is essential for maintaining tissue fluid balance, immune cell trafficking, and overall lymph transport. The contractile function is primarily mediated by a specialized layer of smooth muscle cells known as lymphatic muscle cells (LMCs) that surround collecting lymphatics. LMCs are excitable cells capable of generating action potentials (APs), and each contraction is triggered by an AP, which propagates along the vessel via electrical coupling through gap junctions. Contraction depends on calcium influx, while potassium channels and nitric oxide modulate membrane potential and repolarization. Disruption in contractility can lead to impaired pumping function and clinical lymphedema or immunosuppression-related complications.
Modulation of lymphatic muscle cell contraction frequency and amplitude via calcium signaling, potassium channels, and nitric oxide pathways.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lymphatic Vessel Contractility.